Crystalline drug form

   
   

The present invention relates to a crystalline form of 6-[(2,2-diphenylethyl)amino]-9-(N-ethyl-.beta.-D-ribofuranosyluronamide)-N -(2-{N'-[1-(2-pyridyl)-4-piperidyl]ureido}ethyl)-9H-purine-2-carboxamide and to a process for the preparation of, compositions containing and the uses of such a crystalline form.

La presente invenzione riguarda una forma cristallina di 6-[(2,2-diphenylethyl)amino]-9-(N-ethyl-.beta.-D-ribofuranosyluronamide)-N -(2-{N'-[1-(2-pyridyl)-4-piperidyl]ureido}ethyl)-9H-purine-2-carboxamide e ad un procedimento per la preparazione di, contenere delle composizioni e gli usi di così forma cristallina.

 
Web www.patentalert.com

< Crude and crystalline forms of lercanidipine hydrochloride

< Pyrrolidine derivatives and their use as chymase inhibitor

> Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxyl ic acid amide

> Urea compounds, compositions and methods of use and preparation

~ 00160